Psoriasis

Chronic, immune-mediated inflammatory skin disease driven by IL-23/Th17-axis dysregulation, presenting as well-demarcated erythematous plaques with silvery scale; the most common presentation is chronic plaque psoriasis, though pustular and erythrodermic subtypes also occur.

Phase 1/2 and later readouts in Psoriasis, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

Total attributable cost

$28.4B

$3,592/patient

Drug spend

Not yet sourced

How this is calculated ↗

All severities, physician-diagnosed history (2023 NHIS) · US

All assets in Psoriasis

← Dermatology